Open original FDA record ↗Recall record
- FDA identifier
- Z-1777-2018
- Company in FDA record
- Parker Laboratories, Inc.
- FDA record creation date
- May 9, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is a potential for the gel packets to have leaks in the packet seal.
Source facts
- Action
- Notification letters distributed 4/13/17 instructed customers to perform the following: We request that you quarantine any affected product in your inventory and contact Parker to discuss options for disposition of the recalled products in question. Should you identify any customers to whom the affected product may have already been distributed, we would be happy to provide you with a customer letter that can be transcribed onto your own company letterhead for the purposes of notifying them of this quality issue. Please completed the attached response form as soon as possible and return it to us at the email or fax number listed on the form, so that further arrangements can be made.
- Initiated
- 2017-04-13
- Root cause
- Process control
- Terminated
- 2020-10-26
- Distribution
- The products were distributed to the following US states: CA, FL, GA, IA, IL, OH, TN, and VA. The products were distributed to the following foreign countries: Canada, United Kingdom, and Malta.
- Recall number
- Z-1777-2018
- Recall status
- Terminated
- CDRH record ID
- 163914
- FDA record created
- 2018-05-09
- Recall event number
- 79910